Codexis (CDXS) Retained Earnings (2010 - 2026)
Codexis' (CDXS) quarterly Retained Earnings came in at -$615.5 million in Q1 2026, down 197.22% year-on-year from $633.1 million in Q1 2025, and down 193.64% quarter-over-quarter from $657.3 million in Q4 2025.
Codexis (CDXS) Retained Earnings (2010 - 2026) Analysis & Trends
Codexis' Retained Earnings history runs 17 years deep, the most recent figure standing at -$615.5 million for Q1 2026.
- On a quarterly basis, Retained Earnings fell 197.22% year-over-year to -$615.5 million in Q1 2026; TTM through Mar 2026 was -$615.5 million, a 197.22% decrease from a year earlier, with the FY2025 full-year figure at $657.3 million, up 1263923.08% from the prior year.
- Retained Earnings declined to -$615.5 million in Q1 2026 per CDXS's latest filing, from $657.3 million in the prior quarter.
- Across five years, Retained Earnings topped out at $657.3 million in Q4 2025 and bottomed at -$615.5 million in Q1 2026.
- The 5-year median for Retained Earnings is $126000.0 (2024), against an average of $115.7 million.
- Across the five-year window, Retained Earnings jumped 1263923.08% in 2025 and tumbled 197.22% in 2026, its largest moves.
- Year by year, Retained Earnings stood at $566.1 million in 2022, then rose by 3.19% to $584.1 million in 2023, then sank by 99.99% to $52000.0 in 2024, then soared by 1263923.08% to $657.3 million in 2025, then tumbled by 193.64% to -$615.5 million in 2026.
- Per Business Quant, the three latest CDXS Retained Earnings figures stand at -$615.5 million (Q1 2026), $657.3 million (Q4 2025), and $654.9 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Codexis | 180.63 Mn | 115.49 Mn | 13.18 Mn | -615.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -615.48 Mn |
| Dec 31, 2025 | 657.29 Mn |
| Sep 30, 2025 | 654.90 Mn |
| Jun 30, 2025 | -3,000.00 |
| Mar 31, 2025 | 633.10 Mn |
| Dec 31, 2024 | 52,000.00 |
| Sep 30, 2024 | 126,000.00 |
| Jun 30, 2024 | -531.79 Mn |
| Mar 31, 2024 | -509.04 Mn |
| Dec 31, 2023 | 584.14 Mn |
| Sep 30, 2023 | 581.84 Mn |
| Jun 30, 2023 | 579.56 Mn |
| Mar 31, 2023 | 569.92 Mn |
| Dec 31, 2022 | 566.08 Mn |
| Sep 30, 2022 | -408.69 Mn |
| Jun 30, 2022 | -398.69 Mn |
| Mar 31, 2022 | -396.05 Mn |
| Dec 31, 2021 | -387.70 Mn |
| Sep 30, 2021 | 546.56 Mn |
| Jun 30, 2021 | -379.75 Mn |